|
FR14523E
(fr)
|
1911-02-06 |
1911-12-30 |
Daniel German Caswell |
Perfectionnements dans les vélocipèdes
|
|
US4326055A
(en)
|
1977-12-22 |
1982-04-20 |
Hoffmann-La Roche Inc. |
Stilbene derivatives
|
|
DE3202100A1
(de)
|
1982-01-23 |
1983-08-04 |
Basf Ag, 6700 Ludwigshafen |
Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
|
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
JP4001618B2
(ja)
|
1991-12-18 |
2007-10-31 |
ザ ソールク インスチチュート フォア バイオロジカル スタディズ |
レチノイド受容体によって仲介される過程の修飾方法およびそれに有用な化合物
|
|
ATE195716T1
(de)
|
1992-04-22 |
2000-09-15 |
Ligand Pharm Inc |
Retinoid-x rezeptor selektive verbindungen
|
|
US5780676A
(en)
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
US5466861A
(en)
|
1992-11-25 |
1995-11-14 |
Sri International |
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors
|
|
ES2129115T3
(es)
|
1993-01-11 |
1999-06-01 |
Ligand Pharm Inc |
Compuestos que tienen actividad selectiva para los receptores de retinoides x, y medios para la modulacion de procesos mediados por receptores de retinoides x.
|
|
JPH08505852A
(ja)
|
1993-01-11 |
1996-06-25 |
リガンド・ファーマシューティカルズ・インコーポレーテッド |
レチノイドｘレセプターに対する選択性を有する化合物
|
|
US5399586A
(en)
|
1993-03-11 |
1995-03-21 |
Allergan, Inc. |
Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
|
|
JPH08512197A
(ja)
|
1993-04-07 |
1996-12-24 |
リガンド・ファーマシューティカルズ・インコーポレーテッド |
受容体アゴニストのスクリーニング方法
|
|
PL180048B1
(en)
|
1994-08-10 |
2000-12-29 |
Fhoffmann La Roche Ag |
Ligands of retinic acid x-receptors
|
|
CN1121374C
(zh)
|
1994-12-30 |
2003-09-17 |
配位体药物股份有限公司 |
新的三烯类视黄酸化合物及方法
|
|
US5721103A
(en)
|
1994-12-30 |
1998-02-24 |
Ligand Pharmaceuticals Incorporated |
Trienoic retinoid compounds and methods
|
|
JPH09330101A
(ja)
|
1996-06-13 |
1997-12-22 |
Kokusai Chodendo Sangyo Gijutsu Kenkyu Center |
制御装置及び方法
|
|
IT1286031B1
(it)
|
1996-10-24 |
1998-07-07 |
Enichem Spa |
Procedimento per la produzione di polimeri vinilaromatici ad elevato grado di sindiotassia
|
|
US6969711B2
(en)
|
1997-05-26 |
2005-11-29 |
Kowa Company, Ltd. |
Cyclic diamine compounds and medicine containing the same
|
|
US6316503B1
(en)
|
1999-03-15 |
2001-11-13 |
Tularik Inc. |
LXR modulators
|
|
WO2001041704A2
(en)
|
1999-12-13 |
2001-06-14 |
Merck & Co., Inc. |
Method for the prevention and/or treatment of atherosclerosis
|
|
US20030086923A1
(en)
|
1999-12-13 |
2003-05-08 |
Sparrow Carl P. |
Method for the prevention and/or treatment of atherosclerosis
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
CA2471311A1
(en)
|
2001-12-21 |
2003-07-24 |
Pharmacia Corporation |
Aromatic thioether liver x-receptor modulators
|
|
EP1465869B1
(en)
|
2001-12-21 |
2013-05-15 |
Exelixis Patent Company LLC |
Modulators of lxr
|
|
US20050123580A1
(en)
|
2002-02-28 |
2005-06-09 |
Burris Thomas P. |
Method of treating atherosclerosis and hypercholesterolemia
|
|
MXPA04011690A
(es)
|
2002-05-24 |
2005-03-31 |
Pharmacia Corp |
Moduladores de receptor x de higado de sulfona.
|
|
WO2003099769A1
(en)
|
2002-05-24 |
2003-12-04 |
Pharmacia Corporation |
Anilino liver x-receptor modulators
|
|
AU2003272552A1
(en)
|
2002-09-17 |
2004-04-08 |
Pharmacia Corporation |
Aromatic liver x-receptor modulators
|
|
WO2004058175A2
(en)
|
2002-12-23 |
2004-07-15 |
Irm Llc |
Novel use of liver x receptor agonists
|
|
US20050009837A1
(en)
|
2003-05-20 |
2005-01-13 |
City Of Hope |
Modulators of lipid metabolism and methods of use
|
|
JP2005128010A
(ja)
*
|
2003-10-03 |
2005-05-19 |
Takeda Chem Ind Ltd |
インスリン抵抗性改善剤のスクリーニング方法
|
|
AU2004298486A1
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
EP1773781A2
(en)
|
2004-08-03 |
2007-04-18 |
Wyeth |
Indazoles useful in treating cardiovascular diseases
|
|
CA2662965A1
(en)
|
2006-09-19 |
2008-03-27 |
Wyeth |
Use of lxr agonists for the treatment of osteoarthritis
|
|
US9149492B2
(en)
|
2008-10-08 |
2015-10-06 |
Trustees Of Dartmouth College |
Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease
|
|
AU2010209273A1
(en)
*
|
2009-01-28 |
2011-09-01 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
|
|
JP5719340B2
(ja)
|
2009-03-20 |
2015-05-20 |
レティーナ インプラント アーゲー |
能動型網膜インプラント
|
|
WO2013056232A2
(en)
|
2011-10-13 |
2013-04-18 |
Case Western Reserve University |
Rxr agonists compounds and methods
|
|
WO2013090616A1
(en)
|
2011-12-13 |
2013-06-20 |
Io Therapeutics, Inc. |
Autoimmune disorder treatment using rxr agonists
|
|
WO2015038585A1
(en)
|
2013-09-11 |
2015-03-19 |
Trustees Of Dartmouth College |
Method for selectively inhibiting acat1 in the treatment of alzheimer's disease
|
|
WO2015061686A2
(en)
|
2013-10-25 |
2015-04-30 |
St. Jude Children's Research Hospital, Inc. |
Retinoid x receptor-gamma agonists and retinoid x receptor-alpha antagonists for treatment of cancer
|
|
US10100308B2
(en)
|
2014-05-29 |
2018-10-16 |
Trustees Of Dartmouth College |
Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases
|
|
CA2955086A1
(en)
|
2014-08-08 |
2016-02-11 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
EP3318257B1
(en)
|
2015-06-30 |
2021-07-28 |
National University Corporation Okayama University |
Drug for preventing or treating inflammatory bowel disease
|
|
WO2017058866A1
(en)
|
2015-09-28 |
2017-04-06 |
Precision Immune, Inc. |
Anti-trem2 antibodies and uses thereof
|
|
US20190330335A1
(en)
|
2015-10-06 |
2019-10-31 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
EP3368160B1
(en)
|
2015-10-31 |
2023-05-17 |
IO Therapeutics, Inc. |
Treatment of nervous system disorders using thyroid hormone neutral doses of rxr agonists
|
|
EP3570883A2
(en)
*
|
2017-01-17 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Methods of treating neurodegenerative diseases by inducing disease-associated microglia (dam) cells
|
|
JOP20190248A1
(ar)
|
2017-04-21 |
2019-10-20 |
Amgen Inc |
بروتينات ربط مولد ضد trem2 واستخداماته
|
|
DK3601358T5
(da)
|
2017-08-03 |
2024-09-02 |
Alector Llc |
Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf
|
|
AU2018383709B2
(en)
|
2017-12-12 |
2025-09-11 |
Pionyr Immunotherapeutics, Inc. |
Anti-TREM2 antibodies and related methods
|